Department of Urology, University Hospital Ulm, 89075 Ulm, Germany.
DNA Repair (Amst). 2012 Aug 1;11(8):693-701. doi: 10.1016/j.dnarep.2012.05.003. Epub 2012 Jun 5.
Genome-wide association studies (GWAS) have identified several single nucleotide polymorphisms (SNPs) that mildly predict prostate cancer risk. These SNPs are local tagging markers for causal gene alterations. Consideration of candidate genes in the tagged regions would be facilitated by additional information on the particular pathomechanisms which contribute to the observed risk increase. In this study we test for an association of prostate cancer tagging SNPs with alterations in DNA repair capacity, a phenotype that is frequently involved in cancer predisposition. DNA repair capacity was assessed on blood lymphocytes from 128 healthy probands after ionizing irradiation. We used the micronucleus (MN) assay to determine the cellular DNA double-strand break repair capacity and flow cytometry to measure damage induced mitotic delay (MD). Probands were genotyped for a panel of 14 SNPs, each representing an independent prostate cancer risk locus previously identified by GWAS. Associations between germline variants and DNA repair capacity were found for the SNPs rs1512268 (8p21), rs6983267 (8q24) and rs10993994 (10q11). The most significant finding was an association of homozygous rs10993994 T-allele carriers with a lower MN frequency (p=0.0003) and also a decreased MD index (p=0.0353). Cells with prostate cancer risk alleles at rs10993994 seem to cope more efficiently with DNA double strand breaks (less MN) in a shorter time (decreased MD index). This intriguing finding imposes concern about the accuracy of repair, with respect to the cancer risk that is mediated by T genotypes. To date, MSMB (microseminoprotein β) is favored as the causal gene at the 10q11 risk locus, since it was the first candidate gene known to be expressionally altered by rs10993994. Based on the present observation, candidate genes from the contexts of DNA repair and apoptosis may be more promising targets for expression studies with respect to the rs10993994 genotype.
全基因组关联研究(GWAS)已经确定了几个轻度预测前列腺癌风险的单核苷酸多态性(SNP)。这些 SNP 是因果基因突变的局部标记物。考虑到标记区域中的候选基因,就需要额外了解导致观察到的风险增加的特定病理机制。在这项研究中,我们测试了前列腺癌标记 SNP 与 DNA 修复能力改变之间的关联,DNA 修复能力是癌症易感性中经常涉及的表型。我们在 128 名健康个体的血液淋巴细胞中评估了 DNA 修复能力,这些个体在受到电离辐射后进行了微核(MN)测定以确定细胞的 DNA 双链断裂修复能力,并使用流式细胞术测量诱导的有丝分裂延迟(MD)。对一组 14 个 SNP 进行了基因分型,每个 SNP 代表先前通过 GWAS 确定的一个独立的前列腺癌风险位点。在 DNA 修复能力和种系变体之间发现了与 SNP rs1512268(8p21),rs6983267(8q24)和 rs10993994(10q11)相关的关联。最显著的发现是 rs10993994 纯合 T 等位基因携带者的 MN 频率较低(p=0.0003)和 MD 指数也降低(p=0.0353)。携带 rs10993994 前列腺癌风险等位基因的细胞似乎能够更有效地应对 DNA 双链断裂(MN 较少),并且时间更短(MD 指数降低)。这一有趣的发现令人担忧,因为修复的准确性与 T 基因型介导的癌症风险有关。到目前为止,MSMB(微半胱氨酸蛋白 β)被认为是 10q11 风险位点的因果基因,因为它是第一个已知由 rs10993994 改变表达的候选基因。基于目前的观察结果,对于 rs10993994 基因型,与 DNA 修复和细胞凋亡相关的候选基因可能是更有希望的表达研究靶标。